RE:RE:RE:ok trying this lolDo you know if that means starting in August (meaning early) or the end of? Also is this from the Prospectus of July 2nd? If it is, I'd say we're probably in a good spot hahahh
cyberman wrote: hi cbgirl, yup, moreso i put the info up as it is definitive to what the company projects, whether they realize it or not is another question that we'll have to wait to be answered....and since there was so much discussion on here and calculations and inquiries of the number of tests we're doing, surely Rebecca would just refer folks to this table and the statements as suggested.
good luck !
capebretongirl wrote: cyberman wrote: The following is a summary of the Company’s business objectives and the milestones associated with attaining those objectives.
| | | | |
Maximize U.S. testing capabilities with staff and equipment to 1,000 COVID-19 Tests (comprising either PCR tests, or antibody tests, or both) per day | Fully staffed lab with validated equipment; capable of processing 1,000 COVID-19 Tests (comprising either PCR tests, or antibody tests, or both) per day | | $2,200,000 (to be funded by cash on hand and proceeds of the Offering) |
Increase COVID-19 Tests capability above 1,000 tests (comprising either PCR tests, or antibody (1) | Increase laboratory staff by three (3) or nine (9) full-time employees (under the Minimum Offering and Maximum Offering scenarios, respectively). Purchase additional equipment and supplies. | | $700,000 to $2,500,000 (to be funded by cash on hand and proceeds of the Offering) |
While this is a large financial outlay for Covid testing purposes only, it appears it will be justified by the expectation that Covid testing in the US will continue for a lengthy period. Ultimately, this is the smart play to take full advantage of the Lab's capabilities. If we get to the point of realizing those 1000 + tests per day, the revenue will be immense - certainly sufficient to fully fund the expeditied clinical trials for Aristotle and to boost the sp. This is a company of broken promises and the only catalyst to move that sp will be the publication of quarterly earnings in the millions. Other companies have seen their sp rocket simply on NRs announcing capabilities and expected revenue and the sp becomes essentially built in prior to their release of quarterly earnings - in SZ's case I don't think we will see the same pattern ( read - investors will want to see actual quarterly numbers). Time will tell.